| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $4.87B | +4.4% |
| Cost of Revenue | $1.12B | -0.9% |
| Gross Profit | $3.75B | +6.1% |
| R&D Expense | $844.9M | -0.9% |
| SG&A Expense | $392.9M | -11.2% |
| Operating Income | $1.12B | +38.2% |
| Pre-tax Income | $2.42B | +84.1% |
| Income Tax | $522.1M | +71.0% |
| Net Income | $1.90B |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.27B | -5.7% |
| Accounts Receivable | $497.3M | +0.4% |
| Current Assets | $8.66B | -0.2% |
| Total Assets | $11.96B | +8.8% |
| Current Liabilities | $2.00B | +5.0% |
| Total Liabilities | $2.15B | +4.8% |
| Stockholders' Equity | $9.81B | +9.8% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.99B | +2.2% |
| Capital Expenditures | $65.0M | -52.4% |
| Investing Cash Flow | -$278.9M | +74.8% |
| Financing Cash Flow | -$1.81B | -75.6% |
| Free Cash Flow | $1.92B | +6.4% |
| +88.1% |
| EPS (Basic) | $6.32 | +92.7% |
| EPS (Diluted) | $6.18 | +92.5% |